Transactions
10
Insider / COLGATE PALMOLIVE CO
Newman Brian
Director at COLGATE PALMOLIVE CO
- Company
- COLGATE PALMOLIVE CO
- First filing on record
- October 3, 2025
- Latest trade on record
- October 1, 2026
- SEC filings
- EDGAR ↗
Newman Brian, Director at COLGATE PALMOLIVE CO, has disclosed 10 transactions in CL, CVS since October 3, 2025: 0 purchases (0 open-market buys) and 1 sale, worth about $10.8M at the reported prices. The latest was filed October 2, 2026, 1 day after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
1.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Newman Brian made no purchases and 1 sale worth $225K, plus 8 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Newman Brian has traded 1 stock on record; the largest by dollars is CVS.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 8 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 9 | 150,839 | $10.5M |
| F | Shares withheld for tax | 1 | 2,478 | $225K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 9 | 0 | 1 · $225K |
| 2025 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CL | Other A | October 1, 2026 | October 2, 2026 | 1d | 214 | $87 | $19K | Form 4 ↗ | ||
| CL | Other A | July 1, 2026 | July 2, 2026 | 1d | 209 | $89 | $19K | Form 4 ↗ | ||
| CVS | Sell F | May 31, 2026 | June 1, 2026 | 1d | 2,478 | $91 | $225K | Form 4 ↗ | ||
| CL | Other A | May 11, 2026 | May 13, 2026 | 2d | 2,424 | — | — | derivative | Form 4 ↗ | |
| CL | Other A | May 11, 2026 | May 13, 2026 | 2d | 2,075 | — | — | Form 4 ↗ | ||
| CL | Other A | April 1, 2026 | April 3, 2026 | 2d | 210 | $89 | $19K | Form 4 ↗ | ||
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 125,748 | $72 | $9.0M | derivative | Form 4 ↗ | |
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 19,493 | $72 | $1.4M | Form 4 ↗ | ||
| CL | Other A | January 2, 2026 | January 6, 2026 | 4d | 238 | $79 | $19K | Form 4 ↗ | ||
| CL | Other A | October 1, 2025 | October 3, 2025 | 2d | 228 | $82 | $19K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 2, 2026 | Form 4 | 0001225208-26-008101 | 1 | published | EDGAR ↗ |
| July 2, 2026 | Form 4 | 0001225208-26-006374 | 1 | published | EDGAR ↗ |
| June 1, 2026 | Form 4 | 0000064803-26-000088 | 1 | published | EDGAR ↗ |
| May 13, 2026 | Form 4 | 0001225208-26-005240 | 2 | published | EDGAR ↗ |
| April 3, 2026 | Form 4 | 0001225208-26-004362 | 1 | published | EDGAR ↗ |
| April 2, 2026 | Form 4 | 0000064803-26-000042 | 2 | published | EDGAR ↗ |
| January 6, 2026 | Form 4 | 0001225208-26-000336 | 1 | published | EDGAR ↗ |
| October 3, 2025 | Form 4 | 0001225208-25-008431 | 1 | published | EDGAR ↗ |
Other insiders at COLGATE PALMOLIVE CO
- Mahoney Michael F Chairman, President & CEO 30 rows
- BOERNER CHRISTOPHER S. Chief Executive Officer 24 rows
- KIRBY J SCOTT Director 20 rows
- Wallace Noel R. Chairman, President & CEO 19 rows
- Finucane Anne A. Director 18 rows
- HUNDMEJEAN MARTINA Director 18 rows
- SUTULA STANLEY J III Chief Financial Officer 15 rows
- Tsourapas Panagiotis COO, CD, EMEA, APac, Skin 15 rows
- AGUIRRE FERNANDO Director 13 rows
- Malcolm Gregory EVP and Controller 12 rows
Everyone on file, with contracts and lobbying under the company's name: COLGATE PALMOLIVE CO.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 8 | 10 | October 3, 2025 | October 2, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.